Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview

• Published in: Cells (Basel, Switzerland) Vol. 10; no. 6; p. 1407
• Main Authors: López-Camarillo, César, Ruíz-García, Erika, Salinas-Vera, Yarely M., Silva-Cázares, Macrina B., Hernández-de la Cruz, Olga N., Marchat, Laurence A., Gallardo-Rincón, Dolores
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 06-06-2021; MDPI
• Subjects: Angiogenesis; Apoptosis; Biomarkers; Cancer therapies; Cell adhesion & migration; Cell cycle; Cell division; Cell growth; Cell migration; co-regulation networks; Drug resistance; Endocrine disorders; Epigenetics; Gene expression; Genomes; Kinases; long non-coding RNAs; Medical prognosis; Metastasis; MicroRNAs; miRNA; Mitochondrial DNA; Non-coding RNA; Ovarian cancer; Post-transcription; Proteins; Review; Reviews; Tumorigenesis; Tumors
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells10061407

Non-coding RNAs are emergent elements from the genome, which do not encode for proteins but have relevant cellular functions impacting almost all the physiological processes occurring in eukaryotic cells. In particular, microRNAs and long non-coding RNAs (lncRNAs) are a new class of small RNAs transcribed from the genome, which modulate the expression of specific genes at transcriptional and posttranscriptional levels, thus adding a new regulatory layer in the flux of genetic information. In cancer cells, the miRNAs and lncRNAs interactions with its target genes and functional pathways are deregulated as a consequence of epigenetic and genetic alterations occurring during tumorigenesis. In this review, we summarize the actual knowledge on the interplay of lncRNAs with its cognate miRNAs and mRNAs pairs, which interact in coregulatory networks with a particular emphasis on the mechanisms underlying its oncogenic behavior in ovarian cancer. Specifically, we reviewed here the evidences unraveling the relevant roles of lncRNAs/miRNAs pairs in altered regulation of cell migration, angiogenesis, therapy resistance, and Warburg effect. Finally, we also discussed its potential clinical implications in ovarian cancer and related endocrine disease therapies.